Sanara Stock Gains From New US Distribution Deal With ChemoMouthPieceZacks Investment Research • 09/12/24
Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLCGlobeNewsWire • 09/11/24
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call DatesGlobeNewsWire • 07/30/24
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call DatesGlobeNewsWire • 04/29/24
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerGlobeNewsWire • 04/05/24
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call DatesGlobeNewsWire • 03/13/24
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023GlobeNewsWire • 02/22/24
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen PeptidesGlobeNewsWire • 01/03/24
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound HealingGlobeNewsWire • 11/30/23
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call DatesGlobeNewsWire • 10/30/23
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product UpdatesGlobeNewsWire • 10/10/23
Sanara MedTech: Surgical Sales Set To Accelerate While Post Acute Care Platform DevelopsSeeking Alpha • 09/13/23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products BusinessGlobeNewsWire • 08/02/23